{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Ischemia&page=2", "query": { "condition": "Retinal Ischemia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Ischemia&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Ischemia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T04:35:36.199Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03730779", "title": "Oxygen Therapy for Retinal Ischemia", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Retinal Ischemia" ], "interventions": [ { "name": "Hyperoxia", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-11-30", "completion_date": "2020-01-01", "has_results": false, "last_update_posted_date": "2020-03-09", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03730779" }, { "nct_id": "NCT07290244", "title": "Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Open Angle Glaucoma (OAG)", "NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)" ], "interventions": [ { "name": "ER-100 epigenetic therapy", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Life Biosciences Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 18, "start_date": "2026-03-02", "completion_date": "2032-03", "has_results": false, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 4, "location_summary": "Glendale, California • Boston, Massachusetts • New York, New York + 1 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07290244" }, { "nct_id": "NCT04356716", "title": "Sildenafil for Treatment of Choroidal Ischemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Choroidal Ischemia", "Vitelliform Macular Dystrophy", "Age-related Macular Degeneration", "Central Serous Retinopathy", "Retinitis Pigmentosa" ], "interventions": [ { "name": "Sildenafil", "type": "DRUG" }, { "name": "Standard of Care Sildenafil", "type": "OTHER" }, { "name": "Ocular Coherence Tomography-Angiography (OCT-A)", "type": "DIAGNOSTIC_TEST" }, { "name": "Visual Acuity (VA)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2014-11-11", "completion_date": "2020-02-18", "has_results": true, "last_update_posted_date": "2025-07-04", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04356716" }, { "nct_id": "NCT06583395", "title": "Quest to Analyze One Thousand Humans Meditating", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Amyotrophic Lateral Sclerosis (ALS)", "Angina, Stable", "Anxiety", "Asthma", "Atrial Fibrillation", "Cancer Brain", "Cancer, Breast", "Cancer Colon", "Cancer, Lung", "Cancer, Ovarian", "Cancer Prostate", "Cancer Skin", "Throat Cancer", "Lymphoma", "Cancer, Thyroid", "Cancer, Other", "Cerebral Palsy", "Chronic Fatigue Syndrome", "Cluster Headache", "Chronic Obstructive Pulmonary Disease (COPD)", "Chronic Kidney Diseases", "Crohn Disease", "Deafness", "Depression", "Diabetes", "Eczema", "Epilepsy", "Fibroids", "Fibromyalgia", "Heart Failure", "Hypertension", "Hyperthyroidism", "Hypothyroidism", "Irritable Bowel Syndrome (IBS)", "Infertility", "Lyme Disease", "Macular Degeneration", "Migraine", "Multiple Allergies", "Multiple Sclerosis", "Osteoarthritis", "Osteoporosis", "Ovarian Cysts", "Parkinson Disease", "Phantom Limb Pain", "Psoriasis", "Post Traumatic Stress Disorder (PTSD)", "Rheumatoid Arthritis", "Sjogrens Disease", "Spinal Cord Injury", "Spinal Stenosis", "Stroke", "Tension Headache", "Tinnitus", "Ulcerative Colitis" ], "interventions": [ { "name": "Advanced multi-component meditation practice", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Tobias Moeller-Bertram", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 3000, "start_date": "2021-12-05", "completion_date": "2025-03-25", "has_results": false, "last_update_posted_date": "2024-11-01", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "Palm Desert, California", "locations": [ { "city": "Palm Desert", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06583395" }, { "nct_id": "NCT00406471", "title": "Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ischemic Central Retinal Vein Occlusion" ], "interventions": [ { "name": "Ranibizumab (Lucentis)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Greater Houston Retina Research", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 20, "start_date": "2005-05", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2013-03-14", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00406471" }, { "nct_id": "NCT00464581", "title": "Lucentis for Treatment of Macular Edema", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cystoid Macular Edema" ], "interventions": [], "intervention_types": [], "sponsor": "Retina Institute of Hawaii", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "90 Years", "sex": "ALL", "summary": "Up to 90 Years" }, "enrollment_count": 30, "start_date": "2007-05", "completion_date": "2009-12", "has_results": false, "last_update_posted_date": "2012-05-28", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "Honolulu, Hawaii", "locations": [ { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT00464581" }, { "nct_id": "NCT03475173", "title": "New Non-invasive Modalities for Assessing Retinal Structure and Function", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ischemic Optic Neuropathy", "Branch Retinal Artery Occlusion", "Hemianopia", "Leber Hereditary Optic Neuropathy", "Acute Zonal Occult Outer Retinopathy" ], "interventions": [ { "name": "LSFG-NAVI", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Randy Kardon", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 500, "start_date": "2019-05-06", "completion_date": "2028-03-01", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03475173" }, { "nct_id": "NCT01225146", "title": "Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ischemia", "Retinal Vein Occlusion", "Pathologic Processes", "Retinal Diseases", "Eye Diseases" ], "interventions": [ { "name": "ranibizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David M. Brown, M.D.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2010-10", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2017-08-14", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01225146" }, { "nct_id": "NCT00841373", "title": "Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Retinal Ischemia" ], "interventions": [ { "name": "Panretinal Photocoagulation", "type": "PROCEDURE" }, { "name": "Panretinal Photocoagulation and intravitreal injection of ranibizumab", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Southern New England Retina Associates", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2007-07", "completion_date": "2010-01", "has_results": false, "last_update_posted_date": "2014-11-19", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT00841373" }, { "nct_id": "NCT01064505", "title": "Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Optic Atrophy", "Non-arteritic Anterior Ischemic Optic Neuropathy" ], "interventions": [ { "name": "QPI-1007 at various doses", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Quark Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 48, "start_date": "2010-02", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2013-05-13", "last_synced_at": "2026-10-22T04:35:36.199Z", "location_count": 22, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Los Angeles, California + 19 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01064505" } ] }